Potential antiviral therapies for coronavirus disease 2019 (COVID-19)

The novel coronavirus disease (COVID-2019) caused by severe acute respiratory syndrome coronavirus (called SARS-CoV-2) emerged in China in December 2019 and then spread rapidly to more than 200 countries around the world, including the United States, Spain, Italy, the United Kingdom, Germany, France...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Jasdeep, Singhal, Divya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989131/
http://dx.doi.org/10.1016/B978-0-323-90769-9.00036-0
_version_ 1784683099839266816
author Singh, Jasdeep
Singhal, Divya
author_facet Singh, Jasdeep
Singhal, Divya
author_sort Singh, Jasdeep
collection PubMed
description The novel coronavirus disease (COVID-2019) caused by severe acute respiratory syndrome coronavirus (called SARS-CoV-2) emerged in China in December 2019 and then spread rapidly to more than 200 countries around the world, including the United States, Spain, Italy, the United Kingdom, Germany, France, Japan, and South Korea, resulting in more than 208,112 deaths worldwide. As there is no approved vaccine or therapeutic available to control the COVID-2019 pandemic, scientists across the world are trying every possible way to find antivirals specific to this virus. In this urgent situation, parallel to the development of new vaccines and drugs, many previously approved antiviral drugs of broad range such as arbidol, interferon alfa, chloroquine, remdesivir, and favipiravir are presently undergoing clinical trials against COVID-19. So far some positive findings have been obtained, and here we present a thorough overview of all possible antiviral medicines that can control this pandemic of SARS-CoV-2.
format Online
Article
Text
id pubmed-8989131
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-89891312022-04-11 Potential antiviral therapies for coronavirus disease 2019 (COVID-19) Singh, Jasdeep Singhal, Divya Data Science for COVID-19 Article The novel coronavirus disease (COVID-2019) caused by severe acute respiratory syndrome coronavirus (called SARS-CoV-2) emerged in China in December 2019 and then spread rapidly to more than 200 countries around the world, including the United States, Spain, Italy, the United Kingdom, Germany, France, Japan, and South Korea, resulting in more than 208,112 deaths worldwide. As there is no approved vaccine or therapeutic available to control the COVID-2019 pandemic, scientists across the world are trying every possible way to find antivirals specific to this virus. In this urgent situation, parallel to the development of new vaccines and drugs, many previously approved antiviral drugs of broad range such as arbidol, interferon alfa, chloroquine, remdesivir, and favipiravir are presently undergoing clinical trials against COVID-19. So far some positive findings have been obtained, and here we present a thorough overview of all possible antiviral medicines that can control this pandemic of SARS-CoV-2. 2022 2022-01-14 /pmc/articles/PMC8989131/ http://dx.doi.org/10.1016/B978-0-323-90769-9.00036-0 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Singh, Jasdeep
Singhal, Divya
Potential antiviral therapies for coronavirus disease 2019 (COVID-19)
title Potential antiviral therapies for coronavirus disease 2019 (COVID-19)
title_full Potential antiviral therapies for coronavirus disease 2019 (COVID-19)
title_fullStr Potential antiviral therapies for coronavirus disease 2019 (COVID-19)
title_full_unstemmed Potential antiviral therapies for coronavirus disease 2019 (COVID-19)
title_short Potential antiviral therapies for coronavirus disease 2019 (COVID-19)
title_sort potential antiviral therapies for coronavirus disease 2019 (covid-19)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989131/
http://dx.doi.org/10.1016/B978-0-323-90769-9.00036-0
work_keys_str_mv AT singhjasdeep potentialantiviraltherapiesforcoronavirusdisease2019covid19
AT singhaldivya potentialantiviraltherapiesforcoronavirusdisease2019covid19